Telomir Pharmaceuticals, Inc. Business Finance Contracts & Agreements
8 Contracts & Agreements
- Loan Agreements (1 contract)
- Trust Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (4)
- Representatives Warrant, dated February 13, 2024 (Filed With SEC on February 13, 2024)
- Underwriting Agreement, dated as of February 8, 2024, by and among the Company, Kingswood Investments, division of Kingswood Capital Partners, LLC and the other underwriters named... (Filed With SEC on February 13, 2024)
- Form of Common Stock Purchase Warrant, by and between the Company and certain investors from January 2023 through March 2023 (Filed With SEC on December 19, 2023)
- Form of Representatives Warrant (Filed With SEC on December 19, 2023)
- Form of Underwriting Agreement (Filed With SEC on December 19, 2023)
- Debt Conversion Agreement, dated November 30, 2023, between Telomir Pharmaceuticals, Inc., and the Bay Shore Trust (Filed With SEC on December 14, 2023)
- Promissory Note and Loan Agreement, dated June 15, 2023, by and between Telomir Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on December 14, 2023)
- Common Stock Purchase Warrant, dated June 15, 2023, between Telomir Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on December 14, 2023)
